Breakthrough Therapy Designation is a process designed by the FDA to expedite the development and review of drugs that show substantial improvement over existing therapies for serious or life-threatening conditions. This designation allows for more intensive guidance from the FDA and eligibility for rolling review, potentially bringing promising treatments to patients faster.